Your browser is no longer supported. Please, upgrade your browser.
MRK Merck & Co., Inc. monthly Stock Chart
MRK [NYSE]
Merck & Co., Inc.
IndexDJIA S&P500 P/E20.09 EPS (ttm)4.13 Insider Own0.10% Shs Outstand2.53B Perf Week-3.36%
Market Cap209.33B Forward P/E13.09 EPS next Y6.34 Insider Trans-2.91% Shs Float2.53B Perf Month-3.05%
Income10.53B PEG3.22 EPS next Q1.43 Inst Own76.40% Short Float0.48% Perf Quarter10.29%
Sales47.19B P/S4.44 EPS this Y58.90% Inst Trans-1.32% Short Ratio1.52 Perf Half Y15.61%
Book/sh10.94 P/B7.58 EPS next Y10.83% ROA12.20% Target Price95.94 Perf Year-1.13%
Cash/sh4.40 P/C18.85 EPS next 5Y6.25% ROE39.30% 52W Range65.25 - 92.64 Perf YTD-8.82%
Dividend2.44 P/FCF61.26 EPS past 5Y-1.10% ROI19.20% 52W High-10.48% Beta0.43
Dividend %2.94% Quick Ratio1.10 Sales past 5Y2.10% Gross Margin72.10% 52W Low27.10% ATR1.65
Employees71000 Current Ratio1.30 Sales Q/Q-7.60% Oper. Margin25.40% RSI (14)45.99 Volatility2.18% 2.11%
OptionableYes Debt/Eq1.12 EPS Q/Q14.70% Profit Margin22.20% Rel Volume0.83 Prev Close83.15
ShortableYes LT Debt/Eq0.95 EarningsJul 31 BMO Payout57.70% Avg Volume7.95M Price82.93
Recom1.90 SMA20-1.99% SMA500.12% SMA2001.42% Volume6,607,027 Change-0.26%
Aug-03-20Upgrade Goldman Neutral → Buy $91 → $105
Jun-12-20Downgrade Wolfe Research Outperform → Peer Perform
Feb-27-20Initiated Barclays Overweight $93
Jan-07-20Initiated RBC Capital Mkts Sector Perform $99
Oct-17-19Resumed BofA/Merrill Neutral $90
Aug-16-19Initiated SVB Leerink Outperform
Jul-03-19Initiated Mizuho Buy $97
May-28-19Initiated Goldman Neutral
May-13-19Upgrade Atlantic Equities Neutral → Overweight
Oct-16-18Reiterated Citigroup Buy $70 → $79
Oct-09-18Resumed Guggenheim Buy
Apr-23-18Upgrade Goldman Neutral → Buy
Apr-17-18Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-05-18Upgrade Barclays Equal Weight → Overweight $62 → $64
Mar-12-18Upgrade Leerink Partners Mkt Perform → Outperform
Feb-14-18Reiterated Leerink Partners Mkt Perform $67 → $66
Feb-07-18Reiterated Morgan Stanley Equal-Weight $60 → $63
Jan-16-18Upgrade SunTrust Hold → Buy
Nov-28-17Resumed BofA/Merrill Buy $64
Nov-24-17Reiterated Deutsche Bank Hold $62 → $59
Sep-25-20 04:25PM  
10:39AM  
Sep-24-20 04:25PM  
07:00AM  
Sep-23-20 04:25PM  
01:28PM  
Sep-22-20 05:19PM  
04:25PM  
04:07PM  
08:40AM  
Sep-21-20 04:25PM  
12:30PM  
08:25AM  
06:45AM  
06:45AM  
06:16AM  
03:08AM  
02:19AM  
Sep-20-20 12:30PM  
10:20AM  
08:25AM  
08:25AM  
Sep-19-20 10:20AM  
Sep-18-20 06:05PM  
04:25PM  
06:45AM  
Sep-17-20 05:02PM  
04:54PM  
04:25PM  
Sep-16-20 04:25PM  
02:04PM  
11:04AM  
06:45AM  
Sep-15-20 04:23PM  
12:53PM  
09:51AM  
07:00AM  
06:45AM  
Sep-14-20 05:40PM  
04:39PM  
04:34PM  
04:00PM  
03:49PM  
01:41PM  
12:48PM  
11:15AM  
10:30AM  
09:55AM  
09:38AM  
08:01AM  
06:45AM  
Sep-13-20 02:43PM  
03:37AM  
Sep-11-20 11:51AM  
11:47AM  
10:20AM  
Sep-10-20 10:38AM  
06:45AM  
Sep-09-20 04:25PM  
11:14AM  
09:52AM  
06:45AM  
Sep-08-20 04:39PM  
04:25PM  
04:15PM  
11:39AM  
10:02AM  
06:45AM  
06:30AM  
06:30AM  
05:26AM  
Sep-07-20 04:25PM  
Sep-04-20 04:25PM  
12:20PM  
09:03AM  
06:45AM  
Sep-03-20 06:38PM  
04:25PM  
02:48PM  
10:56AM  
10:12AM  
Sep-02-20 04:29PM  
04:25PM  
11:43AM  
06:45AM  
Sep-01-20 07:47PM  
11:45AM  
09:00AM  
Aug-31-20 04:25PM  
07:20AM  
06:00AM  
Aug-30-20 11:30AM  
Aug-28-20 04:25PM  
03:05PM  
Aug-27-20 05:25PM  
04:26PM  
Aug-26-20 04:39PM  
04:25PM  
02:36PM  
Aug-25-20 04:25PM  
Merck & Co., Inc. provides healthcare solutions worldwide. The company offers therapeutic and preventive agents for cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases; neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. It provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, esophageal, thyroid, cervical, and brain cancers; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. In addition, the company offers drugs for hepatocellular and merkel cell carcinoma; antibiotic and anti-inflammatory drugs for infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, bovine, and swine; vaccines for poultry; parasiticides for sea lice in salmon; and antibiotics and vaccines for fish. Further, it provides companion animal products; diabetes mellitus treatment and anthelmintic products for dogs and cats; products to treat fleas, ticks, mosquitoes, and sandflies; horse fertility management products for swine; and dog, cat, and horse vaccines. Additionally, the company offers services and solutions that focus on engagement, clinical, and health analytics. Merck & Co., Inc. has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Almac Discovery Ltd.; Skyhawk Therapeutics, Inc.; Ridgeback Biotherapeutics; Shanghai Junshi Biosciences Co., Ltd.; and FUJIFILM Corporation. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers; and physicians and physician distributors, veterinarians, and animal producers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chattopadhyay SanatExe V-P & Pres. MMDAug 13Sale83.0110,380861,67667,373Aug 17 06:36 PM
Clyburn FrankEVP, Chief Commercial OfficerAug 05Option Exercise0.0018,876099,639Aug 06 04:53 PM
Clyburn FrankEVP, Chief Commercial OfficerAug 05Sale81.5518,8761,539,27480,763Aug 06 04:53 PM
Gerberding Julie L.EVP Strat Comm, GI Pub PolicyJul 17Option Exercise0.0018,111062,862Jul 20 04:53 PM
Gerberding Julie L.EVP Strat Comm, GI Pub PolicyJul 17Sale80.0036,2852,902,97626,577Jul 20 04:53 PM
BRUN LESLIE ADirectorMay 07Option Exercise0.005,00006,948May 07 04:48 PM
WEEKS WENDELL PDirectorMay 07Option Exercise0.005,00005,100May 07 04:50 PM
BRUN LESLIE ADirectorMay 07Sale75.465,000377,3001,948May 07 04:48 PM
WEEKS WENDELL PDirectorMay 07Sale76.025,000380,104100May 07 04:50 PM
Nally MichaelEVP, Chief Marketing OfficerMay 05Option Exercise76.862,345180,23712,054May 06 05:14 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 05Option Exercise76.863,283252,33129,401May 06 05:15 PM
Fleming MichaelSVP Chief Ethics & Com OfficerMay 05Option Exercise76.861,29099,1497,304May 06 05:16 PM
Clyburn FrankEVP, Chief Commercial OfficerMay 05Option Exercise76.863,752288,37982,611May 06 05:17 PM
Clyburn FrankEVP, Chief Commercial OfficerMay 04Option Exercise77.671,904147,88479,797May 06 05:17 PM
Fleming MichaelSVP Chief Ethics & Com OfficerMay 04Option Exercise77.6769253,7486,252May 06 05:16 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 04Option Exercise77.671,21294,13626,715May 06 05:15 PM
Zachary JenniferEVP, General CounselMay 04Option Exercise77.675,772448,3119,489May 06 05:13 PM
Nally MichaelEVP, Chief Marketing OfficerMay 04Option Exercise77.671,298100,81610,274May 06 05:14 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 03Option Exercise77.6787567,96125,934May 05 04:48 PM
Fleming MichaelSVP Chief Ethics & Com OfficerMay 03Option Exercise77.671,541119,6896,089May 05 04:42 PM
Gerberding Julie L.EVP Strat Comm, GI Pub PolicyJan 13Option Exercise0.0082,5480139,111Jan 15 05:15 PM
Gerberding Julie L.EVP Strat Comm, GI Pub PolicyJan 13Sale89.34102,0739,118,86537,038Jan 15 05:15 PM
Nally MichaelEVP, Chief Marketing OfficerOct 30Option Exercise0.002,28706,196Nov 01 05:07 PM
MIZELL STEVENEVP, Chief HR OfficerOct 30Option Exercise0.004,57404,574Nov 01 05:07 PM
Clyburn FrankEVP, Chief Commercial OfficerOct 30Option Exercise0.002,287073,032Nov 01 05:06 PM
Scholefield James HEVP,Chief Info&Digital OfficerOct 30Option Exercise0.0011,436011,436Nov 01 05:04 PM